FEELING FOGGY, DISTRACTED, DEMOTIVATED? DON’T LET BRAIN FATIGUE HOLD YOU BACK
Brain fatigue causes symptoms like forgetfulness and difficulty concentrating. BRAND'S® Essence of Chicken unlocks the crucial link between diet and brain fatigue, highlighting the importance of amino acids for brain health. KUALA LUMPUR, Malaysia, Aug. 12, 2024 /PRNewswire/ -- Have you ever sat down to start a task at work only to find your mind drawing blanks?...
Sumedang Regency and Docquity Launch AI-Driven Health Platform to Tackle Tuberculosis, Stunting, and Hypertension
SUMEDANG, Indonesia, Aug. 12, 2024 /PRNewswire/ -- Docquity, a leading health tech company established in 2015, is proud to announce its expansion into the B2G sector with the launch of the Puskesmas AI platform in partnership with Sumedang Regency, West Java. This initiative builds on the success of Docquity's social platform, which...
Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China
SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- On August 6, 2024, the msRDN System (SyMapCath I®/ SYMPIONEER S1®), developed by Suzhou/China-based SyMap Medical Ltd. (SyMap Medical), was approved by the National Medical Products Administration (NMPA) of China and granted a Class III Medical Devices Certificate of Registration (National Medical Device Registration No. 20243011383/20243011384). The msRDN system consists of a disposable...
IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Two New Autoimmune Disease Indications
SHANGHAI, NANJING, China and SAN JOSE, Calif., Aug. 12, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, today announced that the investigational new drug (IND) application for its fully human anti-BCMA chimeric antigen receptor autologous T cell injection (Equecabtagene Autoleucel，Eque-cel) has been approved by the...
German Stem Cell Expert Leads Delegation to Boost Sino-German Health & Educational Cooperation
BAODING, China, Aug. 12, 2024 /PRNewswire/ -- A landmark German delegation, led by world-renowned stem cell expert Prof. Dato' Sri Dr. Mike Chan, concluded a three-day visit to Baoding, China, marking a significant step in international health cooperation. The visit, from July 11-13, reciprocated an earlier Chinese governmental visit to Germany in...
The San Ignacio Hospital project in Peru was officially handed over
BEIJING, Aug. 12, 2024 /PRNewswire/ -- On 1 August local time, the San Ignacio Hospital project in Peru, constructed by POWERCHINA, successfully passed the final acceptance of the owner and obtained the official handover certificate. This project is the first hospital project formally handed over by POWERCHINA in Peru, and is another high-quality project contributed by POWERCHINA to Peru's infrastructure. ...
Alphamab Oncology to Present the Latest Clinical Data of Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024
SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 in patients with platinum-resistant ovarian cancer and patients with advanced HER2-positive (IHC 3+) solid tumors, will be presented as posters at the 2024 European Society for Medical Oncology Congress (ESMO Congress...
AsiaMedic launches customised AI virtual assistantwith Enterprise SG affiliated startup MIEA Health
WhatsApp integrated AI virtual assistant expected to reduce call handling time, enabling AsiaMedic to serve its customers more efficiently and effectively. SINGAPORE, Aug. 12, 2024 /PRNewswire/ -- SGX Catalist-listed AsiaMedic Limited (the "Company" and together with its subsidiaries, the "Group"), a leading health screening provider in Singapore, has launched an AI virtual assistant on WhatsApp to enhance customer...
GenScript Biotech Reports First Half 2024 Results
Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy revenue and a 75.4% rise in gross profit, showcasing strong performance across key segments. Focused on Innovation and Efficiency: Investing heavily in...
Pulnovo Medical Announces First Enrollment in Singapore for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease
SHANGHAI, Aug. 9, 2024 /PRNewswire/ -- Pulnovo Medical Limited,a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the launch of Asia's first international multi-center clinical study of Percutaneous Pulmonary Artery Denervation (PADN) for the treatment of PH associated with left heart disease. This exciting event took place at...
